Xiaohong Shu, a professor at Dalian Medical University. Peer-reviewed Publications (First/corresponding author): 1. Increased brain uptake of pterostilbene loaded folate modified micellar delivery system. Drug Deliv. 2022;29(1):3071-3086. 2. Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabine resistant pancreatic cancer cells. Phytomedicine. 2021;91:153711. 3. Heterocellular Contact Can Dictate Arterial Function. Circ Res. 2019;124(10):1473-1481. 4. Structural optimization of diphenylpyrimidine derivatives (DPPYs) as potent Bruton's tyrosine kinase (BTK) inhibitors with improved activity toward B leukemia cell lines. Eur J Med Chem. 2017;126:444-455. 5. Diffusion Efficiency and Bioavailability of Resveratrol Administered to Rat Brain by Different Routes: Therapeutic Implications. Neurotherapeutics. 2015;12(2):491-501. Research Support: Key project of Education Department of Liaoning Province (No. LJKZ0827) Title: Synthesis of resveratrol derivatives targeting STAT3 and their anti-glioma studies. Role: PI National Natural Science Foundation (No. 81672945) Title: Resveratrol-mediated STAT3 signaling regulates the chemosensitivity of temozolomide in glioblastoma. Role: PI National Natural Science Foundation (No. 81072063) Title: Study on metabolic patterns of resveratrol in primary brain malignancies and their correlation with anticancer activity. Role: PI